Trade Bioventix PLC - BVXP CFD

Trading Conditions

• TypeThis financial market is available for CFD trading.Learn more about:CFDs: CFD
• Spread: 0.5316
• Long position overnight funding adjustmentLong position overnight funding adjustmentMargin. Your investment£1,000.00Overnight funding adjustmentCharges from full value of position-0.02127 %(-£1.06)Trade size with leverage ~ £5,000.00Money from leverage ~ £4,000.00Go to platform: -0.02127%
• Short position overnight funding adjustmentShort position overnight funding adjustmentMargin. Your investment£1,000.00Overnight funding adjustmentCharges from full value of position-0.000648 %(-£0.03)Trade size with leverage ~ £5,000.00Money from leverage ~ £4,000.00Go to platform: -0.00065%
• Overnight funding adjustment time: 21:00 (UTC)
• Currency: GBP
• Min traded quantity: 1
• Margin: 20.00%
• Stock exchange: Great Britain
• Commission on trade: 0%
• Guaranteed stop premiumA guaranteed stop-loss (GSL) fee is only charged if the GSL is triggered. Please consult the Charges and Fees section of our website for more details.: 1%

• Margin. Your investment: £1,000.00
• Overnight funding adjustmentCharges from full value of position: -0.02127 %
  (-£1.06)

• Margin. Your investment: £1,000.00
• Overnight funding adjustmentCharges from full value of position: -0.000648 %
  (-£0.03)

Key Stats

• Prev. Close: N/A
• Open: N/A
• 1-Year Change: N/A
• Day's Range: N/A

Trade Bioventix PLC - BVXP

What is Bioventix PLC (BVXP)?

Bioventix PLC is a British biotechnology company specializing in the development and supply of high-affinity monoclonal antibodies for diagnostic and research applications. The company focuses on producing antibodies that are used in various immunoassay tests, which are critical for detecting and measuring substances in clinical diagnostics. Bioventix's products are utilized by global diagnostic companies to enhance the accuracy and reliability of medical tests. The company operates primarily through licensing agreements and royalty income generated from its antibody technologies. Bioventix emphasizes research and development to create antibodies targeting a range of biomarkers relevant to disease diagnosis and monitoring. Its antibodies contribute to advancements in healthcare by supporting the development of diagnostic tools for conditions such as cardiovascular diseases, cancer, and endocrine disorders. The company maintains collaborations with other entities in the life sciences sector to expand its product portfolio and applications. Bioventix's operations are centered in the United Kingdom, and it serves an international customer base within the medical diagnostics industry.

Bioventix PLC Stock Price Today: Live Overview

The price today is shaped by market dynamics, with Duke Capital Ltd currently trading at £16.0158. The price has fluctuated between £19.97 and £20.97, showing a daily percentage move of 0%.

FAQ: Bioventix PLC (BVXP)

What is the current price of BVXP stock?

The price at this moment is £16.0158.

Does BVXP pay dividends?

Bioventix PLC pays dividends via cash distributions (if applicable).

Does BVXP have a formal corporate presence or regional headquarters in the UAE?

Bioventix PLC does not have an official office or subsidiary in the UAE and operates via partners.

What is BVXP best known for?

The company is most famous for developing high-affinity antibodies for diagnostic use.

What assets are typically shown together with BVXP?

Commonly shown alongside BVXP: Volkswagen AG (Pfd), Fraport, China Merchants Bank